European Medicines Agency Launches EudraPharm - The European Medicines Database
Main Category: IT / Internet / E-mailAlso Included In: Primary Care / General Practice; Public Health; Veterinary
Article Date: 07 Dec 2006 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The European Medicines Agency has launched a new public database designed to facilitate access to information about medicines available in the European Union.
The database, called EudraPharm, is a long-term project to give on-line access to information about all medicines, both human and veterinary, available to EU citizens. The database can be accessed at: http://www.eudrapharm.eu
In the first phase the database gives access to information about medicines that have been authorised by the European Commission following assessment by the European Medicines Agency. These are mainly innovative new medicines, intended for treatment of diseases such as different types of cancer, AIDS/HIV, diabetes, neurodegenerative disorders and rare conditions ('orphan drugs'). All of these so-called 'centrally authorised medicines' are approved for use in each of the 25 EU Member States and also in Iceland, Liechtenstein and Norway.
European Commission Vice-President Günter Verheugen, responsible for Enterprise and Industry, welcomed EudraPharm as a "great initiative to provide consumers with more information about their medicines. This database gives people the opportunity to check if they are in doubt, which creates a safer environment for users of medicines."
EMEA Executive Director Thomas Lönngren said: "Once fully developed, this database will be the reference point for independent information about all medicines available to Europeans, no matter whether these medicines have been authorised at EU or national level."
The database includes the summary of product characteristics, package leaflets and the labelling of medicinal products. It currently gives access to information only in English, but information in the other official EU languages will be available at a later phase, together with improved search functions. The Agency is working with medicines agencies in each Member State and the European Commission on the long-term objective of including information on all medicines approved through national procedures.
###
Notes:
1. All information in EudraPharm is updated weekly to ensure that the latest information is always available.
2. EudraPharm was created in accordance with Article 57, 1(l) of Regulation (EC) No 726/2004.
3. More information on the work of the European Commission's pharmaceutical unit can be found here http://ec.europa.eu/enterprise/pharmaceuticals/index_en.htm.
4. This press release, together with other information about the work of the European Medicines Agency, can be found on the EMEA website: http://www.emea.europa.eu.
For further information please go to:
European Medicines Agency And
EudraPharm
Visit our it / internet / e-mail section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/58402.php>
APA
http://www.medicalnewstoday.com/releases/58402.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



